48,830
edits
Difference between revisions of "SMARCB1-deficient renal medullary carcinoma"
Jump to navigation
Jump to search
SMARCB1-deficient renal medullary carcinoma (view source)
Revision as of 13:49, 29 October 2021
, 13:49, 29 October 2021→IHC
(→IHC) |
|||
| Line 106: | Line 106: | ||
*AE1/AE3 +ve. | *AE1/AE3 +ve. | ||
*Cyclin D1 +ve.<ref name=pmid22686875/> | *Cyclin D1 +ve.<ref name=pmid22686875/> | ||
A panel: | |||
*AE1/AE3, cyclin D1, CK7, PAX8, p63, INI-1, L-ALK, RCC, CKIT, GATA3, CK34betaE12, CK5/6, vimentin. | |||
==Sign out== | |||
<pre> | |||
Left Kidney, Radical Nephrectomy: | |||
- RENAL MEDULLARY CARCINOMA, see comment. | |||
-- Margin POSITIVE for carcinoma. | |||
-- Please see synoptic report. | |||
- Four lymph nodes POSITIVE for carcinoma of six (4 positive/6). | |||
</pre> | |||
==See also== | ==See also== | ||